Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date

Felten R, Scher F, Sagez F, Chasset F, Arnaud L

Drug Design, Development and Therapy 2019, 13:1535-1543

Published Date: 8 May 2019